(NASDAQ: MDWD) Mediwound's forecast annual revenue growth rate of 39.36% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Mediwound's revenue in 2024 is $18,686,000.On average, 4 Wall Street analysts forecast MDWD's revenue for 2024 to be $221,709,650, with the lowest MDWD revenue forecast at $218,371,372, and the highest MDWD revenue forecast at $225,933,218. On average, 3 Wall Street analysts forecast MDWD's revenue for 2025 to be $294,478,590, with the lowest MDWD revenue forecast at $276,652,920, and the highest MDWD revenue forecast at $314,462,152.
In 2026, MDWD is forecast to generate $497,698,603 in revenue, with the lowest revenue forecast at $421,987,921 and the highest revenue forecast at $573,409,286.